Loading page…

Report overview

The report marks EMS's 60th anniversary and highlights its peptide platform and 2024 launches, including medicines based on liraglutide. It reports BRL 403 million invested in R&D. Environmental disclosures include water reuse reaching 10.58%, gross Scope 1 emissions of 20,186.761, and total waste generated of 9,512.72 tons.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language
Pages
File size

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Assurance

Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Renewable energy
Water consumption
Waste
Employees

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services